Navigation Links
World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
Date:6/25/2009

GIA announces the release of a comprehensive global report on Nanomedicine markets. The global Nanomedicine market continues to register robust growth largely fueled by unique properties of nanoparticles that provide novel and improved advantages, introduction of novel products, healthy rise in funding across the globe, and increased hype around nanotechnology.

San Jose, CA (PRWEB) June 25, 2009 -- Nanomedicine represents a principal domain of nanotechnology that offers capability to significantly change the course of treatment of life-threatening diseases. Unlike other therapies, nanomedicine enhances efficacy and significantly minimizes adversities associated with standard therapeutics. The application of nanotechnology in the form of nanomedicine in areas including nano drug delivery, nanoanalytical contrast reagents, nanobiomaterials, and nanopharmaceuticals has been surging at a stable rate. Recent years saw implementation of several programs by the industry to bridge the gap between outcomes of clinical research and commercial products. As a result, the present nanobiomaterial product pipeline poses a healthy picture with numerous novel products for use in health care applications, primarily in the form of coatings. Further, research and development in the nanomedicine market is expected to offer several novel products that can effectively improve the health of patients suffering from health disorders and illnesses.

Drug delivery market represents the largest application area, while the Biomaterials segment represents the fastest growing application segment for nanomedicine over the years 2006 through 2015.

The nanomedicine market is highly fragmented and is characterized by the presence of several key and niche players. Major market participants in the nanomedicine market include Abraxis BioScience Inc., AMAG Pharmaceuticals Inc, Arrowhead Research Corporation, Crucell N.V., Flamel Technologies S.A., Elan Corporation Plc, Enzon Pharmaceuticals Inc., Life Technologies Corporation, Nanosphere Inc., Nektar Therapeutics, Novavax Inc., Oxonica Plc, Par Pharmaceutical Companies Inc., Starpharma Holdings Limited, and Wyeth Pharmaceuticals Inc., among others.

The report titled "Nanomedicine: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., covers major market dynamics, trends, issues, and competition pertaining to the market. Analytical estimates and projections on market size have been presented in terms of dollar sales over the time period 2006-2015. The report enumerates recent developments, mergers, acquisitions and other strategic industry activities. The study analyzes the nanomedicine market by the following application areas - Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials and Other Applications.

For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Nanomedicine_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press (at) StrategyR (dot) com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/nanomedicine_biomaterials/drug_delivery/prweb2493834.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. A Worldwide Milestone in Cell Analysis - 40 Years of Flow Cytometry
2. A*STAR scientists invent the worlds only controllable molecule gear of minuscule size of 1.2nm
3. Paris Dates for CPhI Worldwide 2010
4. A-WIT Technologies Releases World's First Low Cost C Stamp(TM) Based Biotechnology Laboratory in a Box
5. The Worlds Smallest Hero! Rexin-G, Targeted Therapy for Metastatic Cancers
6. Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy
7. The World's Leading IP Strategists Revealed
8. Jatrophaworld Training 2009: 2nd Generation nonfood Biofuel crops Knowledge Platform
9. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
10. RSCI Announces World-Leading Stem Cell Science Advisory Board
11. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/24/2016)... 2016  Regular discussions on a range of subjects including ... two entities said Poloz. Speaking at a lecture ... , he pointed to the country,s inflation target, which is ... "In certain areas there ... common economic goals, why not sit down and address strategy ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):